Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com RELEASE FROM VOLUNTARY ESCROW 28 August 2026 – Melbourne, Australia ( 27 August 2026 – Minneapolis, MN United States)...
Release from Voluntary Escrow
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Imricor Medical Systems, Inc. has announced the release of certain Class A Common Stock from voluntary escrow in accordance with ASX Listing Rule. The filing specifies the number of securities and their respective release dates from escrow. This announcement is authorized by Steve Wedan, the Executive Chair, President, and CEO of Imricor.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Imricor Medical Systems, Inc. on 6ix
Earlier from Imricor Medical Systems
- Imricor and Philips Launch Commercial iMR Lab Solution
- Imricor U.S. Commercial Momentum Accelerates
- 1H 2026 Investor Presentation
- 2026 Q2 Form 10-Q
- Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission
Later from Imricor Medical Systems
- FDA Accepts Imricor PMA Manufacturing Module
- S&P DJI Announces September 2026 Quarterly Rebalance
- Application for quotation of securities - IMR
- Cleansing Notice
- FDA Completes Review of Third PMA Module
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems